Rebopag 50 mg (Eltrombopag)
| Active Ingredient | Eltrombopag |
|---|---|
| Indication: | Low platelet count due to ITP or HCV infection |
| Manufacturer: | MSN Laboratories |
| Packaging | 7 tablets in 1 strip |
| Strength | 50mg |
| Delivery Time | 6 To 15 days |
Rebopag 50 mg contains Eltrombopag, a medication used to treat low platelet counts in patients with chronic immune thrombocytopenia (ITP), hepatitis C-associated thrombocytopenia, or severe aplastic anemia. It works by stimulating the bone marrow to produce more platelets, reducing the risk of bleeding and the need for platelet transfusions.
This oral tablet is typically prescribed when other treatments like corticosteroids or immunoglobulins are ineffective. It should be taken exactly as prescribed by your doctor, usually on an empty stomach or as directed. Regular blood tests are necessary to monitor platelet levels and liver function.
Rebopag 50 mg offers a targeted therapy that improves quality of life in patients suffering from chronic blood disorders, helping to manage symptoms more effectively.








There are no reviews yet.